He, L., Habibovic, P., & van Rijt, S. (2025). Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment. Journal of Controlled Release, 388, Article 114289. https://doi.org/10.1016/j.jconrel.2025.114289
He, L., Anbardan, Z. J., Habibovic, P., & van Rijt, S. (2024). Doxorubicin- and Selenium-Incorporated Mesoporous Silica Nanoparticles as a Combination Therapy for Osteosarcoma. ACS Applied Nano Materials, 7(22), 25400 - 25411. https://doi.org/10.1021/acsanm.4c04294